Latest MS research news

Latest MS research news | 12 February 2013

Interdependence and contributions of sun exposure and vitamin D to MRI measures in MS

This study looked at the relationship of sun exposure history, supplementation and environmental factors to vitamin D levels in multiple sclerosis patients and evaluated the associations ...

From MSIF

Latest MS research news | 12 February 2013

A Web-based tool for personalised prediction of long-term disease course in patients with MS

This study group looked at the first web-based prognostic calculator in MS which is capable of delivering individualised estimates of disease progression, called the Evidence-Based Decision ...

From MSIF

Latest MS research news | 05 February 2013

Validation of the automated method VIENA: An accurate, precise, and robust measure of ventricular enlargement

This study from Amsterdam looked at the validation of the automated method VIENA (Ventricular Image Evaluation, using Normalization, of Atrophy) for measuring the percentage ...

From MSIF

Latest MS research news | 05 February 2013

The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination

In this study from France they looked at the role of the androgen receptor in myelin repair. As males are less likely to develop MS and if they do they tend to have a more severe disease, these observations have resulted in a lot of interest in the potential protective effects of androgens.

From MSIF

Latest MS research news | 05 February 2013

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride

This interesting pilot study looked at the neuroprotective effects of amiloride in patients with primary progressive MS.

From MSIF

Latest MS research news | 29 January 2013

Tumefactive demyelination: an approach to diagnosis and management

This review article looks at tumefactive demyelination and proposes an approach to diagnosis and management. Tumefactive demyelinating (TD) lesions are larger than those seen in typical MS (>2cm) and may occur in individuals either with or without established MS.

From MSIF

Latest MS research news | 29 January 2013

Renal deterioration in multiple sclerosis patients with neurovesical dysfunction

This research group looked at the prevalence of renal ultrasound (RUS) abnormalities over time in people with MS with lower urinary tract symptoms (LUTS).

From MSIF

Latest MS research news | 29 January 2013

Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment

This review article from the US looks at the pathogenesis of MS which they propose involves the modulation of cellular mechanisms regulating gene expression, based on the integration of epidemiological data, genome-wide association studies and reports of neuroimaging abnormalities in clinically unaffected individuals.

From MSIF

Latest MS research news | 22 January 2013

Impaired social cognition in multiple sclerosis

This study from Germany explored if theory of mind impairments in MS can be detected using the video based Movie for the Assessment of Social Cognition and whether impaired social cognition can occur independently of deficits in memory, processing speed or executive function in this patient population.

From MSIF

Latest MS research news | 22 January 2013

Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis

The researchers from Italy looked at functional MRI (fMRI) patterns of the brain in clinically isolated syndrome (CIS) patients during the performance of attention tasks using the Variable Attentional Control (VAC) task.

From MSIF
 

Latest MS research news

Main MS research areas

Challenges of MS research

Atacicept in multiple sclerosis: a randomised, placebo-controlled, double-blind, phase 2 trial